Predictors of Upper Airway Function and Sleep-disordered Breathing in the Critically Ill

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02112604
Collaborator
(none)
50
1
65.1
0.8

Study Details

Study Description

Brief Summary

This is part 2 of the #NCT01618240 under the same IRB protocol #2010P001919. The primary objective of this study is to examine factors that are related to sleep-disordered breathing and upper airway patency in critically ill patients who have been recently mechanically ventilated. Our primary hypothesize is that sedatives and neuromuscular blocking agents given in the ICU prior to extubation and during the first night following extubation are associated with sleep-disordered breathing. The secondary hypotheses are that duration of mechanical ventilation, BMI, and muscle strength are associated with sleep-disordered breathing during the night after extubation.

The secondary objective is to evaluate if sleep-disordered breathing in the ICU can be predicted by standard pulmonary function testing in the ICU.

Condition or Disease Intervention/Treatment Phase
  • Device: Ventilator
  • Device: Alice PDx
  • Other: Pulmonary function test
  • Other: Muscle strength tests
  • Other: Grip strength measurement
  • Drug: Sedatives and muscle relaxants given in the ICU

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Determining Predictors of Adequate Upper Airway Function in Ventilated Patients
Study Start Date :
Jul 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Ventilated patients

Patients who have been extubated within 24 hours and have been mechanically ventilated for at least 24 hours. Alice PDx, pulmonary function tests, muscle strength tests, grip strength measurements, ventilator, Sedatives and muscle relaxants given in the ICU

Device: Ventilator
Mechanical ventilator used to replace or assist spontaneous breathing.

Device: Alice PDx
Alice PDx is a polysomnography monitor used to study stages of sleep and detect sleep-disordered breathing. The device monitors PO2, airflow, EEG, EOG and abdominal wall movements to detect sleep apnea.

Other: Pulmonary function test
The pulmonary function tests are used to study upper airway patency.

Other: Muscle strength tests
MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement

Other: Grip strength measurement
Grip strength has been shown to be an accurate means of assessing muscle function in the critically ill. Muscle weakness may have an impact on upper airway patency.

Drug: Sedatives and muscle relaxants given in the ICU
Patients in the ICU are administered sedatives, anesthetics, opiods, anti-pyschotics and neuromuscular blocking agents as part of routine care. We hypothesize that the use of these drugs is associated with sleep-disordered breathing following extubation. We will collect the drug doses from the patient's chart.

Outcome Measures

Primary Outcome Measures

  1. Apnea-hypopnea index (AHI) [1 Night after extubation]

    The apnea-hypopnea index (AHI) is calculated the night after extubation via a polysomnography device. An AHI ≥ 5 indicates sleep-disordered breathing and obstructive sleep apnea (OSA).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients admitted to the SICU

  2. Age over 18 years.

  3. Ventilated patients with an endotracheal tube for at least 24 hours.

Exclusion Criteria:
  1. Decreased level of consciousness as defined by a Richmond Agitation Sedation Scale (RASS) of 0.

  2. Non-cooperative patient, CAM score positive for risk of delirium.

  3. For women: pregnancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Matthias Eikermann, MD, PhD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Matthias Eikermann, Director of Research, Critical Care Division; Associate Professor of Anaesthesia, Harvard Medical School, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT02112604
Other Study ID Numbers:
  • 2010P001919B
First Posted:
Apr 14, 2014
Last Update Posted:
Mar 17, 2016
Last Verified:
Mar 1, 2016
Keywords provided by Matthias Eikermann, Director of Research, Critical Care Division; Associate Professor of Anaesthesia, Harvard Medical School, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2016